Docosapentaenoic acid derived metabolites and mediators – The new world of lipid mediator medicine in a nutshell

European Journal of Pharmacology

Volumn 785, Issue , 2016, Pages 108-115

  Weylandt, Karsten H ^a,b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

Docosapentaenoic acid; DPA; Omega 3 polyunsaturated fatty acids; Omega 6 polyunsaturated fatty acids; Resolvin; Specialized pro resolution mediators

Indexed keywords

ANTIINFLAMMATORY AGENT; DOCOSAPENTAENOIC ACID DERIVATIVE; DRUG METABOLITE; FATTY ACID; MARESIN DERIVATIVE; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; PROTECTIN DERIVATIVE; RESOLVIN DERIVATIVE; UNCLASSIFIED DRUG; DOCOSAPENTAENOIC ACID; UNSATURATED FATTY ACID;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; COLITIS; DRUG EFFICACY; DRUG MECHANISM; NONHUMAN; PRIORITY JOURNAL; ANIMAL; DRUG DEVELOPMENT; HUMAN; METABOLISM; PROCEDURES;

ANIMALS; DRUG DISCOVERY; FATTY ACIDS, UNSATURATED; HUMANS;

EID: 84979887621     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2015.11.002     Document Type: Article

References (46)

1. Akiba, S., Murata, T., Kitatani, K., Sato, T., Involvement of lipoxygenase pathway in docosapentaenoic acid-induced inhibition of platelet aggregation. Biol. Pharm. Bull. 23 (2000), 1293–1297.
2. Arita, M., Bianchini, F., Aliberti, J., Sher, A., Chiang, N., Hong, S., Yang, R., Petasis, N.A., Serhan, C.N., Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1. J. Exp. Med. 201 (2005), 713–722.
3. Arnold, C., Markovic, M., Blossey, K., Wallukat, G., Fischer, R., Dechend, R., Konkel, A., von Schacky, C., Luft, F.C., Muller, D.N., Rothe, M., Schunck, W.H., Arachidonic acid-metabolizing cytochrome P450 enzymes are targets of {omega}-3 fatty acids. J. Biol. Chem. 285 (2010), 32720–32733.
4. Aursnes, M., Tungen, J.E., Vik, A., Colas, R., Cheng, C.Y., Dalli, J., Serhan, C.N., Hansen, T.V., Total synthesis of the lipid mediator PD1n-3 DPA: configurational assignments and anti-inflammatory and pro-resolving actions. J. Nat. Prod. 77 (2014), 910–916.
5. Bento, A.F., Claudino, R.F., Dutra, R.C., Marcon, R., Calixto, J.B., {Omega}-3 fatty acid-derived mediators 17(R)-hydroxy docosahexaenoic acid, aspirin-triggered resolvin D1 and resolvin D2 prevent experimental colitis in mice. J. Immunol. 187 (2011), 1957–1969.
6. Chen, J., Jiang, Y., Liang, Y., Tian, X., Peng, C., Ma, K.Y., Liu, J., Huang, Y., Chen, Z.Y., DPA n-3, DPA n-6 and DHA improve lipoprotein profiles and aortic function in hamsters fed a high cholesterol diet. Atherosclerosis 221 (2012), 397–404.
7. Chiang, N., Dalli, J., Colas, R.A., Serhan, C.N., Identification of resolvin D2 receptor mediating resolution of infections and organ protection. J. Exp. Med. 212 (2015), 1203–1217.
8. Chiu, C.Y., Gomolka, B., Dierkes, C., Huang, N.R., Schroeder, M., Purschke, M., Manstein, D., Dangi, B., Weylandt, K.H., Omega-6 docosapentaenoic acid-derived resolvins and 17-hydroxydocosahexaenoic acid modulate macrophage function and alleviate experimental colitis. Inflamm. Res. 61 (2012), 967–976.
9. Colas, R.A., Shinohara, M., Dalli, J., Chiang, N., Serhan, C.N., Identification and signature profiles for pro-resolving and inflammatory lipid mediators in human tissue. Am. J. Physiol.: Cell Physiol. 307 (2014), C39–C54.
10. Dalli, J., Chiang, N., Serhan, C.N., Elucidation of novel 13-series resolvins that increase with atorvastatin and clear infections. Nat. Med. 21 (2015), 1071–1075.
11. Dalli, J., Colas, R.A., Serhan, C.N., Novel n-3 immunoresolvents: structures and actions. Sci. Rep., 3, 2013, 1940.
12. Dangi, B., Obeng, M., Nauroth, J.M., Chung, G., Bailey-Hall, E., Hallenbeck, T., Arterburn, L.M., Metabolism and biological production of resolvins derived from docosapentaenoic acid (DPAn-6). Biochem. Pharmacol. 79 (2010), 251–260.
13. Dangi, B., Obeng, M., Nauroth, J.M., Teymourlouei, M., Needham, M., Raman, K., Arterburn, L.M., Biogenic synthesis, purification, and chemical characterization of anti-inflammatory resolvins derived from docosapentaenoic acid (DPAn-6). J. Biol. Chem. 284 (2009), 14744–14759.
14. Dayaker, G., Durand, T., Balas, L., Total synthesis of neuroprotectin D1 analogues derived from omega-6 docosapentaenoic acid (DPA) and adrenic acid (AdA) from a common pivotal, late-stage intermediate. J. Org. Chem. 79 (2014), 2657–2665.
15. Dobson, E.P., Barrow, C.J., Kralovec, J.A., Adcock, J.L., Controlled formation of mono- and dihydroxy-resolvins from EPA and DHA using soybean 15-lipoxygenase. J. Lipid Res. 54 (2013), 1439–1447.
16. Fischer, R., Konkel, A., Mehling, H., Blossey, K., Gapelyuk, A., Wessel, N., von Schacky, C., Dechend, R., Muller, D.N., Rothe, M., Luft, F.C., Weylandt, K., Schunck, W.H., Dietary omega-3 fatty acids modulate the eicosanoid profile in man primarily via the CYP-epoxygenase pathway. J. Lipid Res. 55 (2014), 1150–1164.
17. Ghasemi Fard, S., Linderborg, K.M., Turchini, G.M., Sinclair, A.J., Comparison of the bioavailability of docosapentaenoic acid (DPA, 22:5n-3) and eicosapentaenoic acid (EPA, 20:5n-3) in the rat. Prostaglandins Leukot Essent Fatty Acids, 90, 2014, 23–26.
18. Green, K.N., Martinez-Coria, H., Khashwji, H., Hall, E.B., Yurko-Mauro, K.A., Ellis, L., LaFerla, F.M., Dietary docosahexaenoic acid and docosapentaenoic acid ameliorate amyloid-beta and tau pathology via a mechanism involving presenilin 1 levels. J. Neurosci. 27 (2007), 4385–4395.
19. Groeger, A.L., Cipollina, C., Cole, M.P., Woodcock, S.R., Bonacci, G., Rudolph, T.K., Rudolph, V., Freeman, B.A., Schopfer, F.J., Cyclooxygenase-2 generates anti-inflammatory mediators from omega-3 fatty acids. Nat. Chem. Biol. 6 (2010), 433–441.
20. Hong, S., Gronert, K., Devchand, P.R., Moussignac, R.L., Serhan, C.N., Novel docosatrienes and 17S-resolvins generated from docosahexaenoic acid in murine brain, human blood, and glial cells. Autacoids in anti-inflammation. J. Biol. Chem. 278 (2003), 14677–14687.
21. Hudert, C.A., Weylandt, K.H., Lu, Y., Wang, J., Hong, S., Dignass, A., Serhan, C.N., Kang, J.X., Transgenic mice rich in endogenous omega-3 fatty acids are protected from colitis. Proc. Natl. Acad. Sci. USA 103 (2006), 11276–11281.
22. Ishida, T., Yoshida, M., Arita, M., Nishitani, Y., Nishiumi, S., Masuda, A., Mizuno, S., Takagawa, T., Morita, Y., Kutsumi, H., Inokuchi, H., Serhan, C.N., Blumberg, R.S., Azuma, T., Resolvin E1, an endogenous lipid mediator derived from eicosapentaenoic acid, prevents dextran sulfate sodium-induced colitis. Inflamm. Bowel Dis. 16 (2009), 87–95.
23. Jones, M.L., Mark, P.J., Keelan, J.A., Barden, A., Mas, E., Mori, T.A., Waddell, B.J., Maternal dietary omega-3 fatty acid intake increases resolvin and protectin levels in the rat placenta. J. Lipid Res. 54 (2013), 2247–2254.
24. Kaur, G., Sinclair, A.J., Cameron-Smith, D., Barr, D.P., Molero-Navajas, J.C., Konstantopoulos, N., Docosapentaenoic acid (22:5n-3) down-regulates the expression of genes involved in fat synthesis in liver cells. Prostaglandins Leukot. Essent. Fat. Acids 85 (2011), 155–161.
25. Li, Y., Dalli, J., Chiang, N., Baron, R.M., Quintana, C., Serhan, C.N., Plasticity of leukocytic exudates in resolving acute inflammation is regulated by MicroRNA and proresolving mediators. Immunity 39 (2013), 885–898.
26. Miller, E., Kaur, G., Larsen, A., Loh, S.P., Linderborg, K., Weisinger, H.S., Turchini, G.M., Cameron-Smith, D., Sinclair, A.J., A short-term n-3 DPA supplementation study in humans. Eur. J. Nutr. 52 (2013), 895–904.
27. Morin, C., Blier, P.U., Fortin, S., Eicosapentaenoic acid and docosapentaenoic acid monoglycerides are more potent than docosahexaenoic acid monoglyceride to resolve inflammation in a rheumatoid arthritis model. Arthritis Res. Ther., 17, 2015, 142.
28. Morin, C., Hiram, R., Rousseau, E., Blier, P.U., Fortin, S., Docosapentaenoic acid monoacylglyceride reduces inflammation and vascular remodeling in experimental pulmonary hypertension. Am. J. Physiol. Heart Circ. Physiol. 307 (2014), H574–H586.
29. Morin, C., Rousseau, E., Fortin, S., Anti-proliferative effects of a new docosapentaenoic acid monoacylglyceride in colorectal carcinoma cells. Prostaglandins Leukot. Essent. Fat. Acids 89 (2013), 203–213.
30. Murphy, M.G., Wright, V., Ackman, R.G., Horackova, M., Diets enriched in menhaden fish oil, seal oil, or shark liver oil have distinct effects on the lipid and fatty-acid composition of guinea pig heart. Mol. Cell. Biochem. 177 (1997), 257–269.
31. Murphy, M.G., Wright, V., Scott, J., Timmins, A., Ackman, R.G., Dietary menhaden, seal, and corn oils differentially affect lipid and ex vivo eicosanoid and thiobarbituric acid-reactive substances generation in the guinea pig. Lipids 34 (1999), 115–124.
32. Pauter, A.M., Olsson, P., Asadi, A., Herslof, B., Csikasz, R.I., Zadravec, D., Jacobsson, A., Elovl2 ablation demonstrates that systemic DHA is endogenously produced and is essential for lipid homeostasis in mice. J. Lipid Res. 55 (2014), 718–728.
33. Purwaha, P., Gu, Y., Kelavkar, U., Kang, J.X., Law, B., Wu, E., Qian, S.Y., LC/ESR/MS study of pH-dependent radical generation from 15-LOX-catalyzed DPA peroxidation. Free Radic. Biol. Med. 51 (2011), 1461–1470.
34. Samuelsson, B., Prostaglandins, thromboxanes, and leukotrienes: formation and biological roles. Harvey Lect. 75 (1979), 1–40.
35. Sasaki, A., Fukuda, H., Shiida, N., Tanaka, N., Furugen, A., Ogura, J., Shuto, S., Mano, N., Yamaguchi, H., Determination of omega-6 and omega-3 PUFA metabolites in human urine samples using UPLC/MS/MS. Anal. Bioanal. Chem. 407 (2015), 1625–1639.
36. Sasaki, A., Fukuda, H., Shiida, N., Tanaka, N., Furugen, A., Ogura, J., Shuto, S., Mano, N., Yamaguchi, H., Erratum to: Determination of omega-6 and omega-3 PUFA metabolites in human urine samples using UPLC/MS/MS. Anal. Bioanal. Chem. 407 (2015), 2939–2940.
37. Serhan, C.N., Pro-resolving lipid mediators are leads for resolution physiology. Nature 510 (2014), 92–101.
38. Serhan, C.N., Chiang, N., Van Dyke, T.E., Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat. Rev. Immunol. 8 (2008), 349–361.
39. Serhan, C.N., Clish, C.B., Brannon, J., Colgan, S.P., Chiang, N., Gronert, K., Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing. J. Exp. Med. 192 (2000), 1197–1204.
40. Serhan, C.N., Dalli, J., Colas, R.A., Winkler, J.W., Chiang, N., Protectins and maresins: New pro-resolving families of mediators in acute inflammation and resolution bioactive metabolome. Biochim. Biophys. Acta 1851 (2015), 397–413.
41. Serhan, C.N., Hamberg, M., Samuelsson, B., Lipoxins: novel series of biologically active compounds formed from arachidonic acid in human leukocytes. Proc. Natl. Acad. Sci. USA 81 (1984), 5335–5339.
42. Serhan, C.N., Hong, S., Gronert, K., Colgan, S.P., Devchand, P.R., Mirick, G., Moussignac, R.L., Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals. J. Exp. Med. 196 (2002), 1025–1037.
43. Sun, Y.P., Oh, S.F., Uddin, J., Yang, R., Gotlinger, K., Campbell, E., Colgan, S.P., Petasis, N.A., Serhan, C.N., Resolvin D1 and its aspirin-triggered 17R epimer. Stereochemical assignments, anti-inflammatory properties, and enzymatic inactivation. J. Biol. Chem. 282 (2007), 9323–9334.
44. Tsuji, M., Murota, S.I., Morita, I., Docosapentaenoic acid (22:5, n-3) suppressed tube-forming activity in endothelial cells induced by vascular endothelial growth factor. Prostaglandins Leukot. Essent. Fat. Acids 68 (2003), 337–342.
45. Weiss, G.A., Troxler, H., Klinke, G., Rogler, D., Braegger, C., Hersberger, M., High levels of anti-inflammatory and pro-resolving lipid mediators lipoxins and resolvins and declining docosahexaenoic acid levels in human milk during the first month of lactation. Lipids Health Dis., 12, 2013, 89.
46. Weylandt, K.H., Chiu, C.Y., Gomolka, B., Waechter, S.F., Wiedenmann, B., Omega-3 fatty acids and their lipid mediators: towards an understanding of resolvin and protectin formation. Prostaglandins Other Lipid Mediat. 97 (2012), 73–82.